ATE359091T1 - Monoklonaler antikörper gegen menschlische nierenkarzinomzellen - Google Patents
Monoklonaler antikörper gegen menschlische nierenkarzinomzellenInfo
- Publication number
- ATE359091T1 ATE359091T1 AT00925425T AT00925425T ATE359091T1 AT E359091 T1 ATE359091 T1 AT E359091T1 AT 00925425 T AT00925425 T AT 00925425T AT 00925425 T AT00925425 T AT 00925425T AT E359091 T1 ATE359091 T1 AT E359091T1
- Authority
- AT
- Austria
- Prior art keywords
- human renal
- monoclonal antibodies
- antibodies against
- carcinoma cells
- against human
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
- A61K51/106—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from kidney or bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3038—Kidney, bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9905942A FR2793497B1 (fr) | 1999-05-10 | 1999-05-10 | Anticorps monoclonal dirige contre les cellules de carcinome renal humain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE359091T1 true ATE359091T1 (de) | 2007-05-15 |
Family
ID=9545417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00925425T ATE359091T1 (de) | 1999-05-10 | 2000-05-10 | Monoklonaler antikörper gegen menschlische nierenkarzinomzellen |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7074613B1 (de) |
| EP (1) | EP1175227B1 (de) |
| JP (1) | JP2002543811A (de) |
| AT (1) | ATE359091T1 (de) |
| AU (1) | AU781426B2 (de) |
| CA (1) | CA2373631A1 (de) |
| CY (1) | CY1107060T1 (de) |
| DE (1) | DE60034330T2 (de) |
| DK (1) | DK1175227T3 (de) |
| ES (1) | ES2284493T3 (de) |
| FR (1) | FR2793497B1 (de) |
| IL (2) | IL146396A0 (de) |
| PT (1) | PT1175227E (de) |
| WO (1) | WO2000067792A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2793497B1 (fr) | 1999-05-10 | 2003-04-18 | Centre Nat Rech Scient | Anticorps monoclonal dirige contre les cellules de carcinome renal humain |
| DK1733736T3 (en) * | 2001-02-07 | 2015-06-01 | Wilex Ag | A process for the production of recombinant antibodies to tumors |
| US20040077081A1 (en) | 2001-02-07 | 2004-04-22 | Egbert Oosterwijk | Hybridoma cell line g250 and its use for producing monoclonal antibodies |
| AU2002367318B2 (en) * | 2002-01-02 | 2007-07-12 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| US20050074901A1 (en) * | 2002-02-13 | 2005-04-07 | John Castracane | Methods and assays for detecting and quantifying the human p53 inducible gene protein |
| US7632496B2 (en) | 2002-07-01 | 2009-12-15 | Wilex Ag | Co-administration of cG250 and IL-2 or IFN-α for treating cancer such as renal cell carcinomas |
| CN111732660B (zh) * | 2020-07-31 | 2020-12-29 | 河北佑仁生物科技有限公司 | 骨髓间充质干细胞和单克隆抗体联合治疗癌症 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4713352A (en) * | 1981-08-31 | 1987-12-15 | Sloan-Kettering Institute For Cancer Reseach | Monoclonal antibody panel for early diagnosis and therapy of renal carcinoma |
| US4650756A (en) * | 1981-08-31 | 1987-03-17 | Sloan Kettering Institute For Cancer Research | Monoclonal antibodies to cell surface antigens of human renal cancer |
| EP0119528B1 (de) * | 1983-03-11 | 1992-05-13 | Sloan-Kettering Institute For Cancer Research | Monoklonale Antikörper gegen menschliche Nierenkrebsantigene und Verfahren |
| EP0366707A1 (de) * | 1987-05-06 | 1990-05-09 | OOSTERWIJK, Egbert | Monoklonale antikörper gegen nierenzellen-karzinom |
| US5145773A (en) | 1989-05-25 | 1992-09-08 | Sloan-Kettering Institute For Cancer Research | Method to detect sensitivity to alpha-interferon therapy |
| US5270202A (en) * | 1989-11-03 | 1993-12-14 | Syamal Raychaudhuri | Anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen |
| US6235280B1 (en) * | 1996-04-12 | 2001-05-22 | Malaya Chatterjee | Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1 |
| FR2793497B1 (fr) | 1999-05-10 | 2003-04-18 | Centre Nat Rech Scient | Anticorps monoclonal dirige contre les cellules de carcinome renal humain |
| WO2001087233A2 (en) * | 2000-05-16 | 2001-11-22 | New York University | Anti-idiotypic antibody against fimh adhesin of uropathogenic type i-fimbriated escherichia coli, compositions and method of use thereof |
-
1999
- 1999-05-10 FR FR9905942A patent/FR2793497B1/fr not_active Expired - Fee Related
-
2000
- 2000-05-10 IL IL14639600A patent/IL146396A0/xx active IP Right Grant
- 2000-05-10 EP EP00925425A patent/EP1175227B1/de not_active Expired - Lifetime
- 2000-05-10 DK DK00925425T patent/DK1175227T3/da active
- 2000-05-10 AU AU44151/00A patent/AU781426B2/en not_active Ceased
- 2000-05-10 ES ES00925425T patent/ES2284493T3/es not_active Expired - Lifetime
- 2000-05-10 JP JP2000616817A patent/JP2002543811A/ja active Pending
- 2000-05-10 CA CA002373631A patent/CA2373631A1/fr not_active Abandoned
- 2000-05-10 WO PCT/FR2000/001258 patent/WO2000067792A1/fr not_active Ceased
- 2000-05-10 PT PT00925425T patent/PT1175227E/pt unknown
- 2000-05-10 US US09/959,911 patent/US7074613B1/en not_active Expired - Fee Related
- 2000-05-10 DE DE60034330T patent/DE60034330T2/de not_active Expired - Lifetime
- 2000-05-10 AT AT00925425T patent/ATE359091T1/de active
-
2001
- 2001-11-08 IL IL146396A patent/IL146396A/en not_active IP Right Cessation
-
2007
- 2007-07-02 CY CY20071100865T patent/CY1107060T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1175227E (pt) | 2007-07-18 |
| DK1175227T3 (da) | 2007-08-27 |
| US7074613B1 (en) | 2006-07-11 |
| IL146396A (en) | 2007-06-17 |
| CY1107060T1 (el) | 2012-10-24 |
| EP1175227B1 (de) | 2007-04-11 |
| EP1175227A1 (de) | 2002-01-30 |
| AU4415100A (en) | 2000-11-21 |
| JP2002543811A (ja) | 2002-12-24 |
| AU781426B2 (en) | 2005-05-26 |
| ES2284493T3 (es) | 2007-11-16 |
| FR2793497A1 (fr) | 2000-11-17 |
| WO2000067792A9 (fr) | 2002-09-12 |
| IL146396A0 (en) | 2002-07-25 |
| CA2373631A1 (fr) | 2000-11-16 |
| WO2000067792A1 (fr) | 2000-11-16 |
| DE60034330T2 (de) | 2007-12-20 |
| DE60034330D1 (de) | 2007-05-24 |
| FR2793497B1 (fr) | 2003-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1107060T1 (el) | Μονοκλωνικο αντισωμα κατευθυνομενο κατα των κυτταρων του ανθρωπινου νεφρικου καρκινωματος | |
| WO1996020219A3 (en) | Murine monoclonal anti-idiotype antibody 3h1 | |
| DE69433663D1 (de) | Antikörper gegen menschliches prostatspezifisches drüsenkallikrein | |
| DK1565489T3 (da) | Internaliserende antistoffer specifikke for RAAG10-celleoverflademålet | |
| NO981745D0 (no) | Monoklonalt antistoff BR110 og anvendelse av dette | |
| ATE382683T1 (de) | Monoklonales antikörper gegen das hcv kernantigen | |
| WO2003024191A3 (en) | Antibodies that bind to cancer-associated antigen cytokeratin 8 and methods of use thereof | |
| OA08485A (fr) | Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas. | |
| NO20004251D0 (no) | Humaniserte anti-CEA monoklonale antistoffer med høy affinitet | |
| NO974852L (no) | Humant <beta>2-integrin-<alfa>-subenhet | |
| ATE378355T1 (de) | Neuer monoklonaler antikörper und antigene gegen nematodenlarven | |
| FI960566A7 (fi) | Monoklonaalinen vasta-aine, joka tunnistaa välisolun pinta-antigeenin | |
| ATE263784T1 (de) | Anti-megakaryozyten monoklonaler antikörper 97a6 | |
| AR023204A1 (es) | Anticuerpos contra la proteina placentaria 13. | |
| WO2003001884A3 (en) | Targeting tumor cell antigens: antibodies useful for the diagnosis, prognosis, and treatment of cancer | |
| IT1317355B1 (it) | Anticorpi policlonali. | |
| TR199600671A2 (tr) | Kronik lenfositik lösemi'ye spesifik monoklonal antikor ve bunu üreten hücre. | |
| ZA200200730B (en) | Human monoclonal antibodies to prostate specific membrane antigen. | |
| ZA996220B (en) | Anti-Fas antibodies. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1175227 Country of ref document: EP |